From the patient perspective: The economic value of seasonal and H1N1 influenza vaccination

Bruce Y. Lee, Kristina M. Bacon, Julie M. Donohue, Ann E. Wiringa, Rachel R. Bailey, Richard K. Zimmerman

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Although studies have suggested that a patient's perceived cost-benefit of a medical intervention could affect his or her utilization of the intervention, the economic value of influenza vaccine from the patient's perspective remains unclear. Therefore, we developed a stochastic decision analytic computer model representing an adult's decision of whether to get vaccinated. Different scenarios explored the impact of the patient being insured versus uninsured, influenza attack rate, vaccine administration costs and vaccination time costs. Results indicated that the cost of avoiding influenza was fairly low (with one driver being required vaccination time). To encourage vaccination, decision makers may want to focus on ways to reduce this time, such as vaccinating at work, churches, or other normally frequented locations.

Original languageEnglish (US)
Pages (from-to)2149-2158
Number of pages10
Issue number11
StatePublished - 2011
Externally publishedYes


  • Economics
  • H1N1
  • Influenza vaccine
  • Patients

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'From the patient perspective: The economic value of seasonal and H1N1 influenza vaccination'. Together they form a unique fingerprint.

Cite this